´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ Á¦29Â÷ Á¤±âÇмú´ëȸ ¹× ÃÑȸ(2ÀÏÂ÷) (¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) : 2020-07-25±³À°ÀÏÀÚ : 2020-07-25
±³À°Àå¼Ò : ¿ÀÇÁ¶óÀÎ & ¿Â¶óÀÎ µ¿½Ã °³ÃÖ ¿¬¼ö±³À° (¿ÀÇÁ¶óÀÎ: °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B)
±³À°ÁÖÁ¦ :
Á¦29Â÷ Á¤±âÇмú´ëȸ ¹× ÃÑȸ(2ÀÏÂ÷) (¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà)ÁÖÃÖ±â°ü : ´ëÇÑ¿µ»óÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ
´ã´çÀÚ : ÁÖÇýÁ¤
¿¬¶ôó : 02-465-9070
À̸ÞÀÏ :
office@intervention.or.kr ±³À°Á¾·ù : ¿µ»óÀÇÇаúÀÇ»çÇÐ, ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ç, ÀÇÇб³À°, ÀÇ·áÁ¤Ã¥, ÀÇ·á¹ý
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
°æ»óºÏµµ±³À°½Ã°£ : 6 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 120,000¿ø
ºñ°í ¿Â¶óÀÎ »çÀüµî·Ï 10000¿ø / ¿ÀÇÁ¶óÀÎ-»çÀüµî·Ï: Á¤È¸¿ø.ÁØȸ¿ø.±âŸ 50000¿ø, Àü¹®ÀÇ 100000¿ø, °øº¸.Àü°øÀÇ 30000¿ø / ¿ÀÇÁ¶óÀÎ-ÇöÀåµî·Ï: Á¤È¸¿ø.ÁØȸ¿ø.±âŸ 70000¿ø, Àü¹®ÀÇ 120000¿ø, °øº¸.Àü°øÀÇ 50000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 07-25 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 08:00~08:10 Predisposing factors for the iliac limb migration after EVAR ±èÇü¿í(Àü³²ÀÇ´ë)
±³À°½Ã°£ 07-25 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 08:10~08:20 Real world Outcome of the Paclitaxel-Eluting Stents for TASC C and D Femoropoliteal Lesions ±Ç·Á¹Î(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 07-25 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 08:20~08:30 Safety and Efficacy of Mynx Vascular Closure Device for the Closure of Common Femoral Artery Access Site in a Situation of Ipsilateral Stent Placement ÀåÇý¹Î(°Ç±¹ÀǾÖ)
±³À°½Ã°£ 07-25 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 08:30~08:40 Percutaneous Intervention for Salvage of Non-Maturing Arteriovenous Fistulas: Which is the Better Approach, Arterial or Venous? ÀÌ»ó¹Î(°æ»óÀÇ´ë)
±³À°½Ã°£ 07-25 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 08:40~08:50 Usefulness and Feasibility of Clinch Knot with a Guidewire in Place for Temporary Hemostasis in Arteriovenous Dialysis Access Intervention ¹Ú¼ºÁØ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 07-25 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 08:50~09:00 Radiologically Guided Placement of Central Venous Ports: Retrospective Analysis of the Clinical Outcome and Associated Risk Factors in 2883 Port Placements at a Single Center Á¤»óÈÆ(Â÷ÀÇ´ë)
±³À°½Ã°£ 07-25 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 09:00~09:50 ÀÎÅͺ¥¼Ç °ü·Ã ÀÇ·áºÐÀïÀÇ ¿¹½Ã¿Í ´ëó¹æ¾È ÀÌ°æ±Ç(¹ý¹«¹ýÀÎ ¿¤ÄÉÀÌÆÄÆ®³Ê½º)
ÈÞ½Ä 07-25 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 09:50~10:10 Coffee Break ()
±³À°½Ã°£ 07-25 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 10:10~10:40 ÀÎÅͺ¥¼Ç°ú ¸ù°ñÀÇ»ç ±èÀ±È¯(ÀüÁÖ¿¹¼öº´¿ø)
±³À°½Ã°£ 07-25 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 10:40~11:00 Treatment of complex vascular malformation ±è°æ·¡(UNC USA)
±³À°½Ã°£ 07-25 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 11:00~11:20 Budd-Chiari Syndrome: East vs. West Penguin-xu Ding(First Affiliated Hospital of Zhengzhou University China)
±âŸ 07-25 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 11:20~12:00 ÃÑȸ ()
±³À°½Ã°£ 07-25 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 12:00~12:40 Experience using the Angio-CT system for Prostate artery embolization Á¤ÇýµÎ(ÈÞ¸Õ¿µ»óÀÇÇм¾ÅÍ)
ÈÞ½Ä 07-25 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 12:40~13:00 Coffee Break ()
±³À°½Ã°£ 07-25 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:00~13:10 The Value of Pre-procedural Magnetic Resonance Imaging in Genicular Artery Embolization for Patients with Osteoarthritic Knee Pain ÃÖÁø¿ì(¼¿ïÀÇ´ë)
±³À°½Ã°£ 07-25 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:10~13:20 Embolization using a new quickly soluble gelatin sponge particle to treat chronic pain in musculoskeletal disorders ¹ÎÁö¿µ(°Ç±¹ÀÇ´ë)
±³À°½Ã°£ 07-25 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:20~13:30 Therapeutic outcomes of embolotherapy of extremity bone arteriovenous malformation with ethanol, coils, and n-butyl cyanoacrylate ±è¶õ(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 07-25 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:30~13:40 Embolosurgery of a localized extracranial arteriovenous malformation: Analysis of angiographic type, embolization technique, and outcome Â÷Áß±Ù(°æºÏÀÇ´ë)
±³À°½Ã°£ 07-25 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:40~13:50 Efficacy and safety of transcatheter arterial embolization for active arterial esophageal bleeding: a single- center experience Alrashidi Ibrahim(¿ï»êÀÇ´ë)
±³À°½Ã°£ 07-25 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 13:50~14:00 Does nonvascularized lymph node transplantation facilitates the lymphangiogenesis? ±è°Ç¿µ(ÀüºÏÀÇ´ë)
±³À°½Ã°£ 07-25 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 14:00~14:15 Large HCC : How/why I do DEB-TACE ¿ÀÁ¤¼®(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 07-25 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 14:15~14:30 Large HCC : How/why I do cTACE ±èȿö(¼¿ïÀÇ´ë)
±³À°½Ã°£ 07-25 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 14:30~14:45 Large HCC : How/why I do Y-90 ±è°æ¹Î(¿¬¼¼ÀÇ´ë)
Åä·Ð 07-25 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 14:45~14:55 Discussion ¼Å¼® À̺´Âù(°í·ÁÀÇ´ë Àü³²ÀÇ´ë)
±³À°½Ã°£ 07-25 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 14:55~15:10 Prostatic artery embolization Á¤ÇýµÎ(ÈÞ¸Õ¿µ»óÀÇÇм¾ÅÍ)
±³À°½Ã°£ 07-25 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 15:10~15:25 Musculoskeletal embolization ÀÌ»óȯ(¾çÁöº´¿ø)
±³À°½Ã°£ 07-25 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 15:25~15:40 AVF ±Ç¿äÇÑ(¾ÆÁÖÀÇ´ë)
Åä·Ð 07-25 °æÁÖȹéÄÁº¥¼Ç¼¾ÅÍ 3Ãþ 300B 15:40~15:50 Discussion ¼º³«Á¾ Àüâȣ(¼¿ïº½¿µ»óÀÇÇаú ºÎ»êÀÇ´ë)